# Preliminary Fast-Completion Triage

Assessment date: 2026-09-24

## Counts

- Official tracked tasks: 32.
- Tier A, nearest to formal completion: 4.
- Tier B, target trial and contract evidence mostly present: 10.
- Selected for this 20-minute relaxed preliminary pass: 3.

Tier A uses the following evidence: current-version target trial completed with a pass-like target result, `quality/contract_audit.json` is `PASS`, and `quality/evidence_surface_card.json` is `PASS`. It does not mean release-ready; all current Tier A tasks still have release blockers.

## Selected tasks

| Task | Existing evidence | Preliminary check | Formal blockers retained |
| --- | --- | --- | --- |
| `eb013-cross-context-evidence-portfolio-005` | Current target `RAW_PASS`; verifier, contract, evidence surface PASS | 17 passed | fixed-container replay; practitioner review; held-out target trials |
| `eb014-sequential-evidence-feedback-002` | Current target `RAW_PASS`; verifier, contract, evidence surface PASS | 3 passed, 1 skipped | trajectory analysis; fixed-container replay; practitioner review |
| `eb015-real-source-replacement-gate-001` | Current target `PASS_AFTER_CONTRACT_REPLAY`; verifier, contract, evidence surface PASS | test suite discovered; 1 skipped, no runnable local case | source rights; file SHA-256 freeze; verifier rebind; fixed-container replay; practitioner review |

The per-task records are stored as `quality/preliminary_completion_20260924.json`. They are deliberately marked `PRELIMINARY_NOT_RELEASE_READY`; no formal `release_status` was changed.

## Not selected

`eb006-research-completion-011` also meets the mechanical Tier A count, but its target evidence is an output-complete timeout/infrastructure-sensitive run. It should be handled after a clean rerun rather than counted as the fastest clean close.

## Next shortest path

1. Run fixed-container replay for the three selected tasks.
2. For `eb014`, add the trajectory analysis.
3. For `eb015`, freeze source rights/hash metadata and rebind the verifier.
4. Schedule practitioner review and held-out target trials; these remain mandatory for formal completion.
